Tags

Type your tag names separated by a space and hit enter

GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Fertil Steril. 2008 Oct; 90(4):1294-6.FS

Abstract

To examine whether the choice of the GnRH analogues used during controlled ovarian hyperstimulation (COH), may influence endometrial receptivity, we studied 712 IVF cycles, in patients undergoing COH with GnRH agonist or antagonist and with the transfer of at least one top-quality embryo. The GnRH agonist group showed significantly higher endometrial thickness and higher pregnancy rate, suggestive of a higher endometrial receptivity, compared with the GnRH antagonist group.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Orvieto R
Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel. raoulo@barzi.health.gov.il
Meltzer S
No affiliation info available
Rabinson J
No affiliation info available
Zohav E
No affiliation info available
Anteby EY
No affiliation info available
Nahum R
No affiliation info available

MeSH

AdultEndometriumFemaleFertility Agents, FemaleFertilization in VitroGonadotropin-Releasing HormoneHumansInfertility, FemaleOvulation InductionPregnancyPregnancy RateTreatment Outcome

Pub Type(s)

Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

18178197

Citation

Orvieto, Raoul, et al. "GnRH Agonist Versus GnRH Antagonist in Ovarian Stimulation: the Role of Endometrial Receptivity." Fertility and Sterility, vol. 90, no. 4, 2008, pp. 1294-6.
Orvieto R, Meltzer S, Rabinson J, et al. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertil Steril. 2008;90(4):1294-6.
Orvieto, R., Meltzer, S., Rabinson, J., Zohav, E., Anteby, E. Y., & Nahum, R. (2008). GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertility and Sterility, 90(4), 1294-6. https://doi.org/10.1016/j.fertnstert.2007.10.022
Orvieto R, et al. GnRH Agonist Versus GnRH Antagonist in Ovarian Stimulation: the Role of Endometrial Receptivity. Fertil Steril. 2008;90(4):1294-6. PubMed PMID: 18178197.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. AU - Orvieto,Raoul, AU - Meltzer,Simion, AU - Rabinson,Jacob, AU - Zohav,Efraim, AU - Anteby,Eyal Y, AU - Nahum,Ravit, Y1 - 2008/01/07/ PY - 2007/09/28/received PY - 2007/10/08/revised PY - 2007/10/08/accepted PY - 2008/1/8/pubmed PY - 2008/11/15/medline PY - 2008/1/8/entrez SP - 1294 EP - 6 JF - Fertility and sterility JO - Fertil Steril VL - 90 IS - 4 N2 - To examine whether the choice of the GnRH analogues used during controlled ovarian hyperstimulation (COH), may influence endometrial receptivity, we studied 712 IVF cycles, in patients undergoing COH with GnRH agonist or antagonist and with the transfer of at least one top-quality embryo. The GnRH agonist group showed significantly higher endometrial thickness and higher pregnancy rate, suggestive of a higher endometrial receptivity, compared with the GnRH antagonist group. SN - 1556-5653 UR - https://www.unboundmedicine.com/medline/citation/18178197/GnRH_agonist_versus_GnRH_antagonist_in_ovarian_stimulation:_the_role_of_endometrial_receptivity_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0015-0282(07)03875-7 DB - PRIME DP - Unbound Medicine ER -
Grapherence [↓22]

Related Citations

More